1(2H)-Quinoxalinecarboxylic acid,2-ethyl-7-fluoro-3,4-dihydro-3-oxo-,1-methylethyl ester,(2S)- (178040-94-3)

Identification
Name:	1(2H)-Quinoxalinecarboxylic acid,2-ethyl-7-fluoro-3,4-dihydro-3-oxo-,1-methylethyl ester,(2S)-
Synonyms:	Opaviraline;HBY-1293;GW-867;GW-420867X;propan-2-yl (2S)-2-ethyl-7-fluoro-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxylate
CAS:	178040-94-3
Molecular Formula:	C₁₄H₁₇FN₂O₃
Molecular Weight:	280.2948
InChI:	InChI=1/C14H17FN2O3/c1-4-11-13(18)16-10-6-5-9(15)7-12(10)17(11)14(19)20-8(2)3/h5-8,11H,4H2,1-3H3,(H,16,18)/t11-/m0/s1
Molecular Structure:
Properties
Flash Point:	206.4°C
Boiling Point:	417.7°C at 760 mmHg
Density:	1.204g/cm³
Refractive index:	1.516
Flash Point:	206.4°C
Safety Data

Other Product

2-Quinoxalinecarboxylic acid,3,4-dihydro-7-(1H-imidazol-1-yl)-3-oxo-6-(trifluoromethyl)-, ethyl ester
2-Quinoxalinecarboxylic acid,7-(4-formyl-1H-imidazol-1-yl)-3,4-dihydro-3-oxo-6-(trifluoromethyl)-,ethyl ester
2-Quinoxalinecarboxylic acid, 3-[(acetyloxy)methyl]-7-fluoro-, ethyl ester,1-oxide
1(2H)-Quinoxalinecarboxylic acid, 2-ethyl-3,4-dihydro-6,7-dimethyl-,ethyl ester, (2S)-
1(2H)-Quinoxalinecarboxylic acid,2-[2-[[2-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]ethyl]amino]-2-oxoethyl]-3,4-dihydro-3-oxo-, phenylmethyl ester, (2R)-
2-Quinoxalinecarboxylic acid,7-[4-[[[[[3-(ethoxycarbonyl)phenyl]amino]carbonyl]oxy]methyl]-1H-imidazol-1-yl]-3,4-dihydro-3-oxo-6-(trifluoromethyl)-, ethyl ester
2-Quinoxalinecarboxylic acid,7-[4-[[[[(3-bromophenyl)amino]carbonyl]oxy]methyl]-1H-imidazol-1-yl]-3,4-dihydro-3-oxo-6-(trifluoromethyl)-, ethyl ester
2-Quinoxalinecarboxylic acid,7-[4-[[[[[4-(ethoxycarbonyl)phenyl]amino]carbonyl]oxy]methyl]-1H-imidazol-1-yl]-3,4-dihydro-3-oxo-6-(trifluoromethyl)-, ethyl ester
2-Quinoxalinecarboxylic acid,3,4-dihydro-7-[4-[[[[(4-methylphenyl)amino]carbonyl]oxy]methyl]-1H-imidazol-1-yl]-3-oxo-6-(trifluoromethyl)-, ethyl ester
2-Quinoxalinecarboxylic acid,7-[4-[[[[(4-bromophenyl)amino]carbonyl]oxy]methyl]-1H-imidazol-1-yl]-3,4-dihydro-3-oxo-6-(trifluoromethyl)-, ethyl ester
2-Quinoxalinecarboxylic acid,3,4-dihydro-3-oxo-7-[4-[[[(phenylamino)carbonyl]oxy]methyl]-1H-imidazol-1-yl]-6-(trifluoromethyl)-, ethyl ester
3-Quinolinecarboxylic acid,1-cyclopropyl-6-fluoro-1,4-dihydro-7-[[4-(1-methylethyl)-2-thiazolyl]methoxy]-4-oxo-, ethyl ester
1(2H)-Quinoxalinecarboxylic acid, 3-ethyl-3,4-dihydro-6,7-dimethyl-,1,1-dimethylethyl ester
2-Quinoxalinecarboxylic acid,3,4-dihydro-6,7-dimethoxy-4-methyl-3-oxo-, ethyl ester
2-Quinoxalinecarboxylic acid,3,4-dihydro-7-(1H-imidazol-1-yl)-6-nitro-3-oxo-
2-Quinoxalinecarboxylic acid,3,4-dihydro-3-oxo-7-(1H-pyrrol-1-yl)-6-(trifluoromethyl)-
2-Quinoxalinecarboxylic acid,3,4-dihydro-3-oxo-7-[4-[[[(phenylamino)carbonyl]oxy]methyl]-1H-imidazol-1-yl]-6-(trifluoromethyl)-
2-Quinoxalinecarboxylic acid,3,4-dihydro-3-oxo-7-[4-[[[(phenylamino)carbonyl]amino]methyl]-1H-imidazol-1-yl]-6-(trifluoromethyl)-
Glycine,N-[[7-(cyclohexylamino)-6-fluoro-1-(2-fluoro-1-methylethyl)-1,4-dihydro-4-oxo-3-quinolinyl]carbonyl]-, ethyl ester
2-Quinoxalinecarboxylic acid, 7-fluoro-3-methyl-, ethyl ester, 1,4-dioxide